肖柳玲｜重庆医科大学｜学者主页

2026

T cells engineered against Dickkopf-1-A2 complex can be used to treat HLA-A2+ solid and hematologic cancers

Yufei Zhang, Wei Xiong, Jianfei Qian, Rui Duan, Qi Guo, Qiang Wang, Wei Wu, Chuanchao Zhang, Yabo Li, Miao Xian, Yong Lu, Nestor F. Esnaola, Jenny C Chang, Liuling Xiao, Ling Zhong, Qing Yi

Nature Communications

DOI

2025

Adoptively transferred tumor-specific IL-9-producing cytotoxic CD8+ T cells activate host CD4+ T cells to control tumors with antigen loss

Liuling Xiao, Rui Duan, Wendao Liu, Chuanchao Zhang, Xingzhe Ma, Miao Xian, Qiang Wang, Qi Guo, Wei Xiong, Pan Su, Ling-Qun Ye, Yabo Li, Ling Zhong, J. Qian, Yong Lu, Zhongming Zhao, Qing Yi

Nature Cancer

DOI

2025

Depletion of myeloid-derived suppressor cells sensitizes murine multiple myeloma to PD-1 checkpoint inhibitors

Wei Xiong, Liuling Xiao, Rui Duan, Qiang Wang, Miao Xian, Chuanchao Zhang, Pan Su, Yabo Li, Ling Zhong, J. Qian, Chengyun Zheng, Qing Yi

Journal for ImmunoTherapy of Cancer

DOI

2025

NPC1 as a novel therapeutic target for induction of pyroptosis in cancers

Chuanchao Zhang, Qiang Wang, Pan Su, J. Qian, Qi Guo, Wei Wu, Rui Duan, Yufei Zhang, You-Li Zu, Ling Zhong, Liuling Xiao, Qing Yi

Biomarker Research

DOI

2024

Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis

Miao Xian, Qiang Wang, Liuling Xiao, Ling Zhong, Wei Xiong, Ling-Qun Ye, Pan Su, Chuanchao Zhang, Yabo Li, R. Orlowski, Feng-Huang Zhan, S. Ganguly, You-Li Zu, Jianfei Qian, Qing Yi

Nature Communications

DOI

2024

Abstract 3606: Tumor-specific CD8+ Tc9 cells activate host CD4+ T cells to control antigen-lost tumors

Liuling Xiao, Qing Yi

Cancer Research

DOI

2024

Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers

J. Qian, Qiang Wang, Liuling Xiao, Wei Xiong, Miao Xian, Pan Su, Maojie Yang, Chuanchao Zhang, Yabo Li, Ling Zhong, S. Ganguly, You-Li Zu, Qing Yi

Journal for ImmunoTherapy of Cancer

DOI

2024

Abstract 2821: Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers

J. Qian, Wang Qiang, Liuling Xiao, Wei Xiong, Miao Xian, Chuanchao Zhang, Yabo Li, Qing Yi

Cancer Research

DOI

2024

Lipid peroxidation of immune cells in cancer

Liuling Xiao, Miao Xian, Chuanchao Zhang, Qi Guo, Qing Yi

Frontiers in Immunology

DOI

2024

P-068 Developing Novel DKK1-A2 CAR-T Cell Therapy for Myeloma and Other Hematologic Malignancies

J. Qian, Wei Xiong, Liuling Xiao, Yufei Zhang, S. Ganguly, Qing Yi

Clinical Lymphoma, Myeloma & Leukemia

DOI

2024

Abstract 364: Targeting LILRB1 to sensitize human myeloma to ferroptosis through disrupting cholesterol homeostasis

Miao Xian, Qing Yi, Qiang Wang, Liuling Xiao, Ling Zhong, Chuanchao Zhang, Yabo Li, J. Qian

Cancer Research

DOI

2022

IL-9/STAT3/fatty acid oxidation–mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity

Liuling Xiao, Xingzhe Ma, Lingqun Ye, Pan Su, Wei Xiong, Enguang Bi, Qiang Wang, Miao Xian, Maojie Yang, J. Qian, Q. Yi

Journal of Clinical Investigation

DOI

2022

A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors

Pan Su, Liuling Xiao, Lingqun Ye, Zhuo Wang, Wei Xiong, Qiang Wang, Xingzhe Ma, Miao Xian, Maojie Yang, You-Li Zu, S. Pingali, J. Qian, Q. Yi

Journal of Hematology & Oncology

DOI

2022

Isolation of adoptively transferred CD8+ T cells in mouse tumor tissues for lipid peroxidation detection

Liuling Xiao, Q. Yi

STAR Protocols

DOI

2021

RARγ activation sensitizes human myeloma cells to carfilzomib treatment through OAS-RNase L innate immune pathway.

Qiang Wang, Zhi-Juan Lin, Zhuo Wang, Lingqun Ye, Miao Xian, Liuling Xiao, Pan Su, Enguang Bi, Yung-Hsing Huang, J. Qian, Lin-Tao Liu, Xingzhe Ma, Maojie Yang, Wei Xiong, You-Li Zu, S. Pingali, Bing Xu, Q. Yi

Blood

DOI

2021

CD36-mediated ferroptosis dampens intratumoral CD8+ T-cell effector function and impairs their antitumor ability

Xingzhe Ma, Liuling Xiao, Lin-Tao Liu, Lingqun Ye, Pan Su, Enguang Bi, Qiang Wang, Maojie Yang, J. Qian, Q. Yi

Cell Metabolism

DOI

2020

Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9

Lin-Tao Liu, Enguang Bi, Xingzhe Ma, Wei Xiong, J. Qian, Lingqun Ye, Pan Su, Qiang Wang, Liuling Xiao, Maojie Yang, Yong Lu, Q. Yi

Nature Communications

DOI

肖柳玲

精选作品

期刊论文

T cells engineered against Dickkopf-1-A2 complex can be used to treat HLA-A2+ solid and hematologic cancers

Adoptively transferred tumor-specific IL-9-producing cytotoxic CD8+ T cells activate host CD4+ T cells to control tumors with antigen loss

Depletion of myeloid-derived suppressor cells sensitizes murine multiple myeloma to PD-1 checkpoint inhibitors

NPC1 as a novel therapeutic target for induction of pyroptosis in cancers

Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis

Abstract 3606: Tumor-specific CD8+ Tc9 cells activate host CD4+ T cells to control antigen-lost tumors

Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers

Abstract 2821: Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers

Lipid peroxidation of immune cells in cancer

P-068 Developing Novel DKK1-A2 CAR-T Cell Therapy for Myeloma and Other Hematologic Malignancies

Abstract 364: Targeting LILRB1 to sensitize human myeloma to ferroptosis through disrupting cholesterol homeostasis

IL-9/STAT3/fatty acid oxidation–mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity

A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors

Isolation of adoptively transferred CD8+ T cells in mouse tumor tissues for lipid peroxidation detection

RARγ activation sensitizes human myeloma cells to carfilzomib treatment through OAS-RNase L innate immune pathway.

CD36-mediated ferroptosis dampens intratumoral CD8+ T-cell effector function and impairs their antitumor ability

Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9

研究方向